Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Aug;97(2):309-310.
doi: 10.4269/ajtmh.17-0373.

Ferroquine Advances

David L Saunders  1
Affiliations
Editorial

Ferroquine Advances

David L Saunders. Am J Trop Med Hyg. 2017 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Saunders D, Vanachayangkul P, Lon C, 2014. Dihydroartemisinin-piperaquine failure in Cambodia. N Engl J Med 371: 484–485. - PubMed
    1. Burrows JN, Duparc S, Gutteridge WE, Hooft van Huijsduijnen R, Kaszubska W, Macintyre F, Mazzuri S, Möhrle JJ, Wells TNC, 2017. New developments in anti-malarial target candidate and product profiles. Malar J 16: 26. - PMC - PubMed
    1. Leong FJ, Li R, Jain JP, Lefèvre G, Magnusson B, Diagana TT, Pertel P, 2014. A first-in-human randomized, double-blind, placebo-controlled, single-and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother 58: 6209–6214. - PMC - PubMed
    1. Charman SA, Arbe-Barnes S, Bathurst IC, Brun R, Campbell M, Charman WN, Chiu FC, Chollet J, Craft JC, Creek DJ, Dong Y, Matile H, Maurer M, Morizzi J, Nguyen T, Papastogiannidis P, Scheurer C, Shackleford DM, Sriraghavan K, Stingelin L, Tang Y, Urwyler H, Wang X, White KL, Wittlin S, Zhou L, Vennerstrom JL, 2011. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci USA 108: 4400–4405. - PMC - PubMed
    1. Lon C, Manning J, Vanachayangkul P, So M, Sea D, Se Y, Gosi P, Lanteri C, Chaorattanakawee S, Sriwichai S, Chann S, Kuntawunginn W, Buathong N, Nou S, Walsh DS, Tyner SD, Juliano JJ, Lin J, Spring M, Bethell D, Kaewkungwal J, Tang D, Chuor CM, Satharath P, Saunders D, 2014. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial. PLoS One 9: e93138. - PMC - PubMed

LinkOut - more resources